Women's health pharmaceutical firm reports loss of $0.20 per share.

2004 APR 5 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories, Inc., (CBRX) announced financial results for the fourth quarter and year ended December 31, 2003.

For the fourth quarter of 2003, the company reported a loss of $7,825,794, or $0.20 per basic and diluted share, on sales of $5,125,725, as compared to a loss of $6,734,160, or $0.19 per basic and diluted share, on sales of $2,346,055 in the fourth quarter of 2002.

Fourth quarter 2004 sales reflect a 118% increase over fourth quarter 2002, as a result of increased sales of Prochieve 8% (progesterone gel), sales of Striant (testosterone buccal system) and sales to our marketing partners.

…